FDA Authorizes Baricitinib Combo for COVID-19 ...Middle East

News by : (Medscape) -
Baricitinib plus remdesivir reduced recovery time in a phase 3 clinical trial of 1033 patients. The treatment is meant for patients who need supplemental oxygen, mechanical ventilation, or ECMO. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Authorizes Baricitinib Combo for COVID-19 )

Also on site :

Most Viewed News
جديد الاخبار